Correlation Between PDS Biotechnology and Lifecore Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Lifecore Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Lifecore Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Lifecore Biomedical, you can compare the effects of market volatilities on PDS Biotechnology and Lifecore Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Lifecore Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Lifecore Biomedical.

Diversification Opportunities for PDS Biotechnology and Lifecore Biomedical

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between PDS and Lifecore is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Lifecore Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lifecore Biomedical and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Lifecore Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lifecore Biomedical has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Lifecore Biomedical go up and down completely randomly.

Pair Corralation between PDS Biotechnology and Lifecore Biomedical

Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the Lifecore Biomedical. In addition to that, PDS Biotechnology is 1.07 times more volatile than Lifecore Biomedical. It trades about -0.03 of its total potential returns per unit of risk. Lifecore Biomedical is currently generating about 0.01 per unit of volatility. If you would invest  864.00  in Lifecore Biomedical on September 2, 2024 and sell it today you would lose (123.00) from holding Lifecore Biomedical or give up 14.24% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

PDS Biotechnology Corp  vs.  Lifecore Biomedical

 Performance 
       Timeline  
PDS Biotechnology Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Lifecore Biomedical 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Lifecore Biomedical are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting fundamental indicators, Lifecore Biomedical reported solid returns over the last few months and may actually be approaching a breakup point.

PDS Biotechnology and Lifecore Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PDS Biotechnology and Lifecore Biomedical

The main advantage of trading using opposite PDS Biotechnology and Lifecore Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Lifecore Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifecore Biomedical will offset losses from the drop in Lifecore Biomedical's long position.
The idea behind PDS Biotechnology Corp and Lifecore Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators